Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 113

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 113
---
 wild animals (CITES), the long-tailed macaque is designated an Appendix II species, which means it is considered not necessarily threatened with extinction, but in which trade must be controlled. 5 Proprietary Information and Micromanagement The Charles River Board strongly believes that disclosure of further detail related to NHPs figures by country, as requested in the shareholder proposal, is detrimental to shareholder interests as it would benefit competitors. Our commitment to annually disclose when a country of origin exceeds 30% of globally sourced NHPs informs shareholders regarding supply chain risk, without disclosure of overly granular confidential, sensitive and potentially proprietary Company information. Proposal Four acknowledges that proprietary information should be omitted. At Charles River’s 2024 Annual Meeting and 2023 Annual Meeting, the proponent put forward substantially similar proposals, which received low shareholder support. The proponent put forward almost identical proposals at both the 2023 Annual Meeting and the 2024 Annual Meeting. Based on our commitment to create and the eventual publication of the NHP Report, the 4 https://azupcriversitestorage01.blob.core.windows.net/storage-account-container/resources/doc_a/ SupplierCodeofConduct.pdf 5 https://cites.org/eng/app/index.php

# 84 majority of shareholders overwhelmingly agreed with our position that the proposal was not in the best interests of the Company by a nearly 2:1 margin in 2023 and even more (by a 3:1 margin) in 2024. The Board strongly believes that our comprehensive actions and disclosure fulfills the proposal’s objective as to disclosure and transparency. We therefore reiterate our recommendation that shareholders should vote AGAINST Proposal Four in our 2025 Proxy Statement. Thank you for your consideration, as well as your support as shareholders. The Board of Directors unanimously recommends a vote “AGAINST” this shareholder proposal. OTHER MATTERS Shareholder Proposals for 2026 Annual Meeting Shareholders who wish to present proposals for inclusion in the proxy statement relating to our Annual Meeting of Shareholders to be held in 2026 may do so by following the procedures prescribed in Rule 14a-8 under the Securities Exchange Act of 1934 (the Exchange Act). To be eligible, shareholder proposals must be received by our Corporate Secretary no later than December 3, 2025. It is suggested that any shareholder proposals be sent by a trackable method (i.e., certified mail, registered mail, overnight courier, etc.) to the Corporate Secretary, Charles River Laboratories International, Inc.,